charles shepherd
Senior Member
- Messages
- 2,239
THE MEA PURPLE BOOKLET - 2016 edition is published today
The 2016 edition of the MEA purple booklet - ME/CFS/PVFS: An Exploration of the Key Clinical Issues - is published today: June 1st 2016
This is a major revision and update of the previous edition with a new layout and an incase in pages from 52 to 132
So it is no longer a booklet - it has become a book!
The MEA purple booklet is our essential guide to ME/CFS that summaries and references (over 300 key references) all the key findings relating to:
Nomenclature and clinical/research definitions of ME and CFS
Epidemiology and co-morbidity
RESEARCH:
Cardiac function
Genetics and gene expression
Infection
Immunology
Muscle
Neurology, neuroimaging, neuroendocrinology, post mortem research
Sleep
CLINICAL ASSESSMENT
Symptoms, examination findings, investigations
Diagnosis and Differential Diagnosis
Disabilty Assessment
MANAGEMENT:
General principles
Drugs aimed at symptom relief
Drugs aimed at the underlying disease process
All aspects of non drug management:
Activity and energy management
Alternative and Complementary Therapies
Benefits
Blood and organ donation
Diet and nutrition
Disability issues
Driving
Education
Employment
Insurance cover
Pregnancy
Relapses and exacerbations
Vaccinations
Prognosis and Quality of Life
Children and Adolescents
Severe ME/CFS
More information on the MEA website:
http://www.meassociation.org.uk/201...ch-masterwork-is-published-today-1-june-2016/
Dr Charles Shepherd
Hon Medical Adviser, MEA
June 1st 2016
The 2016 edition of the MEA purple booklet - ME/CFS/PVFS: An Exploration of the Key Clinical Issues - is published today: June 1st 2016
This is a major revision and update of the previous edition with a new layout and an incase in pages from 52 to 132
So it is no longer a booklet - it has become a book!
The MEA purple booklet is our essential guide to ME/CFS that summaries and references (over 300 key references) all the key findings relating to:
Nomenclature and clinical/research definitions of ME and CFS
Epidemiology and co-morbidity
RESEARCH:
Cardiac function
Genetics and gene expression
Infection
Immunology
Muscle
Neurology, neuroimaging, neuroendocrinology, post mortem research
Sleep
CLINICAL ASSESSMENT
Symptoms, examination findings, investigations
Diagnosis and Differential Diagnosis
Disabilty Assessment
MANAGEMENT:
General principles
Drugs aimed at symptom relief
Drugs aimed at the underlying disease process
All aspects of non drug management:
Activity and energy management
Alternative and Complementary Therapies
Benefits
Blood and organ donation
Diet and nutrition
Disability issues
Driving
Education
Employment
Insurance cover
Pregnancy
Relapses and exacerbations
Vaccinations
Prognosis and Quality of Life
Children and Adolescents
Severe ME/CFS
More information on the MEA website:
http://www.meassociation.org.uk/201...ch-masterwork-is-published-today-1-june-2016/
Dr Charles Shepherd
Hon Medical Adviser, MEA
June 1st 2016